ARTICLE | Clinical News
Lirilumab: Ph II EffiKIR data
February 10, 2017 8:42 PM UTC
Top-line data from the double-blind, French Phase II EffiKIR trial in about 150 elderly AML patients in first complete remission showed that maintenance treatment with 0.1 mg/kg lirilumab every 3 mont...